Artificial intelligence system helps successfully treat cancer patient - Times of India

SINGAPORE: In a first, scientists have used a powerful artificial intelligence (AI) platform, to successfully treat a patient with advanced cancer, completely halting disease progression. The research team successfully utilised a platform called CURATE.AI to continuously identify the optimal doses of each drug to result in a durable response, allowing the patient to resume a completely normal and active lifestyle. The patient with metastatic castration-resistant prostate cancer (MCRPC) was given a novel drug combination consisting of investigational drug ZEN-3694 and enzalutamide, an approved prostate cancer drug. "Dynamic dosing in cancer therapy is not commonly used. In fact, drug dosing changes in oncology are typically performed only to reduce toxicity," said Dean Ho, from National University of Singapore (NUS).